print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Publications
  • linkedin_icon
  • mail_icon
  • print_icon
  • download

How the ‘five Ps’ can close health equity gaps

How Policymakers, Payers, Providers, Patients, and Pharma are each uniquely able to impact health equity – and together, achieve real progress.

How the ‘five Ps’ can close health equity gaps

Of all the forms of inequality, injustice in health is the most shocking.

                                                                                - Martin Luther King

The World Health Organization (WHO) states that health is “a fundamental human right,” but many millions of people around the world remain deprived of this right.1

Health inequities occur due to a wide range of social determinants of health – where we are born, grow and live, access to education and employment, systemic racism, sexism and more – which while deep rooted, are “a consequence of political and economic choices.2”  

The consequences are significant. It is estimated that lack of access to healthcare causes about 15,000 deaths a day.3 While the greatest burden of health inequity falls on people in low- and middle-income countries, health inequity remains a challenge everywhere, including in high-income countries. The USA has the highest rates of avoidable deaths among high-income countries,4 while in Europe, health inequity poses the greatest challenge to achieving public health goals in the coming years.5

Health equity – defined as “when everyone can attain their full potential for health and well-being”6 – benefits us all and makes society stronger and more resilient. It should be a priority for everyone. Achieving health equity requires action and collaboration among all stakeholders involved in health and social systems. 

Here, we look at each of the ‘five Ps’ of health stakeholders – Policymakers, Payers, Providers, Patients, and Pharma – to see where each has the greatest potential to effect meaningful change, and examples of initiatives to close health equity gaps.

Policymakers: Shaping the environment to make change possible 

Perhaps no stakeholder has the potential to make greater inroads into improving healthy equity than policymakers, who can shape health policy and system strategies to address the fundamental political, economic, and social factors that determine health. 

The impact can be wide-reaching. Take A New Public Health Order for Africa for example, a framework developed by the Africa Centres for Disease Control and Prevention (CDC) to strengthen the self-sufficiency of African public health systems. Built on pillars including a strengthened public health workforce, and expanded manufacturing of vaccines, diagnostics and therapeutics, the framework will enable the "second independence of Africa," according to the Director General of the Africa CDC.7

In Europe meanwhile, the JAHEE (Joint Action Health Equity Europe) was formed in 2018 with the aim of greater equity in health outcomes through strengthening cooperation between participating countries. With actions across five policy domains – monitoring, governance, living environments, health systems and migration – the initiative enabled increased levels of national policy action and capacity to address health inequities.8

Payers: Prioritizing value and health outcomes 

Real change requires motivation. The incentives must be there for people to challenge the status quo – this is where payers have a vital role to play as catalysts for change. Still too much healthcare is paid for ‘per service or item’, regardless of the outcome. Value-based payments add incentives by paying providers based on the outcomes of their product or service, or linking payment to value-added services beyond the product.

In the USA, where social determinants such as education, neighborhood, and racism contribute to significant health inequities,4 some states are implementing Medicaid health equity incentives. For example, in Oregon, the Health Authority appointed new coordinated care organizations (CCOs) – essentially networks of providers – which are required to invest in social determinants of health, including food and housing services.9

Providers: Building capacity and capabilities to expand reach  

Individual practices and healthcare professionals can help to reach all patient populations within their local communities. Barriers often exist to under-served populations, such as practice accessibility, lack of health literacy, mistrust of healthcare providers, and provider prejudice. 

In the UK, the UCL Institute of Health Equity published a report with guidance on how healthcare providers can reduce health inequalities through actions on the social determinants of health. These include workforce education and training, involving trusted community members, using plain language, and building respectful relationships with patients.10

In addition, embracing digital healthcare, such as telehealth, can remove travel and accessibility barriers.

Patients: Advocating for health equity 

It is patients who ultimately pay the biggest price for health inequity. But patients are making themselves heard; individuals are increasingly involved in shared decision-making about their own care, and patient advocates are increasingly involved in decisions around healthcare system unmet needs and implementation of solutions.

The Global Patient Think Tank is a diverse group of patient community representatives focused on integrating the patient voice into the movement for universal health coverage (UHC). The group will launch the UHC Compass by December 2024 – a resource packed with information and tools to support patient communities to advance UHC in their country.11  

Pharma: Embracing inclusivity and collaboration 

Because pharma companies are often actively involved throughout the patient journey, they can impact health equity across a broad scope of areas: from disease awareness and health literacy, to making access to diagnosis, care and monitoring more equitable.

One key focus for the industry is improving clinical trial diversity, ensuring treatments are effective across diverse populations and supporting broader patient access. Many companies are taking steps to ensure their trials are accessible to underrepresented groups. The US FDA has issued guidance for companies to implement Diversity Action Plans to support enrollment of participants of historically underrepresented populations,12 and various tools to support individuals from diverse backgrounds to participate.13

Pharma also has the reach and scale to make a lasting impact on health equity through philanthropic collaborations; providing medicines but also laying foundations for a more sustainable future. Gavi, the Vaccine Alliance, has support from several industry partners, supplying millions of vaccine doses, providing essential expertise, and supporting vaccine rollouts.14

Working towards the ‘sixth P’: Progress 

Initiatives supporting health equity can help each of the ‘five Ps’ to fulfil core objectives: from improving public health outcomes for policymakers, through to achieving better outcomes and quality of life for patients. See Figure 1 for the benefits per stakeholder. There are also significant benefits to overall societal welfare, for example through reduced costs, improved productivity, and strengthened societal resilience and inclusivity.

Figure 1: The benefits of healthy equity to the ‘Five Ps’

To maximize the value of health equity initiatives, the following key steps should be considered.

  1.  When identifying the unmet need, work from the ‘ground up’ with local communities to thoroughly understand key issues and related root causes. Leverage data where possible to substantiate the need and highlight the potential benefits of working towards health equity. 
  2.  Identify objectives and action plans that incorporate incentives for accommodating health equity. What will really drive the change you want to see? Leverage existing policies and initiatives to help build your case and create momentum. 
  3.  Partner with other stakeholders wherever possible – ideally at the local level to ensure initiatives are applicable to the local context and recognized by the local community, including patients.  Remember, individually each of the ‘five Ps’ can bring about change. Together, they can create a profound and lasting impact. 
  4.  Monitor and evaluate continually. Reassess what the initiative needs and retailor the approach accordingly as needed. When you see evidence of progress, verify, capture and communicate it as soon as possible. 

The result? Real progress towards closing health equity gaps. And towards a fairer and healthier future. 
​​​​​​​ 
You can find the e-version of this article published in Pharmaceutical Market Europe Magazine here: https://pme.pmlive.com/collections/pme-november-2024/1399c512-a023-11ef-8b79-42010a800017

Download PDF 631.6 KB

References

1 World Health Organization. Health inequities and their causes. 2018. Available at: https://www.who.int/news-room/facts-in-pictures/detail/health-inequities-and-their-causes 

2 Oxfam International. It's time to end extreme inequality. Available at: https://www.oxfam.org/en/take-action/campaigns/fight-inequality-beat-poverty/its-time-end-extreme-inequality 

3 Oxfa. Views & Voices. Why does Oxfam say ‘inequality kills’? We break down the numbers. 2022. Available at: https://views-voices.oxfam.org.uk/2022/01/why-does-oxfam-say-inequality-kills-we-break-down-the-numbers/ 

4 The Lancet Public Health. A missed opportunity to tackle health inequity in the USA? Lancet Public Health. 2024 Aug;9(8):e533. doi: 10.1016/S2468-2667(24)00168-3. PMID: 39095129.

5 EuroHealthNet. EuroHealthNet Foresight: What will public health look like in 2035? https://eurohealthnet.eu/publication/eurohealthnet-foresight-what-will-public-health-look-like-in-2035/ 

6 WHO. Health equity. Available at: https://www.who.int/health-topics/health-equity 

7 Think Global Health. Global Health and the "Second Independence of Africa". 2024. Available at: https://www.thinkglobalhealth.org/article/global-health-and-second-independence-africa 

8 Bucciardini R, Zetterquist P, Rotko T, et al. Addressing health inequalities in Europe: key messages from the Joint Action Health Equity Europe (JAHEE). Arch Public Health. 2023 May 11;81(1):89. doi: 10.1186/s13690-023-01086-3. PMID: 37170153; PMCID: PMC10173226.

9 Health Affairs. To Advance Health Equity, Federal Policy Makers Should Build On Lessons From State Medicaid Experiments. 2021. Available at: https://www.healthaffairs.org/content/forefront/advance-health-equity-federal-policy-makers-should-build-lessons-state-medicaid 

10 UCL Institute of Health Equity. Working for Health Equity: The Role of Health Professionals. 2013. Available at: https://www.instituteofhealthequity.org/resources-reports/working-for-health-equity-the-role-of-health-professionals/the-role-of-health-professionals-exec-summary.pdf

11 International Alliance of Patient Organizations (IAPO). CPTT Communication Deck. Available at: https://www.iapo.org.uk/sites/default/files/files/BCR/GPTT%20communication%20deck%20May%2024.pdf  

12 U.S. FDA. FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies. Available at: https://www.fda.gov/news-events/press-announcements/fda-guidance-provides-new-details-diversity-action-plans-required-certain-clinical-studies 

13 U.S. FDA. Clinical Trial Diversity. Available at: https://www.fda.gov/consumers/minority-health-and-health-equity/clinical-trial-diversity 

14 Gavi. Gavi’s partnership model. Available at: https://www.gavi.org/our-alliance/operating-model/gavis-partnership-model   

Contact our experts

Meike Wenzel

Meike Wenzel

Partner

mail_icon linkedin_icon
Arman Nilforoushan

Arman Nilforoushan

Director

mail_icon linkedin_icon
Marion Rauch

Marion Rauch

Manager

mail_icon
Rebecca De Leeuw

Rebecca De Leeuw

Consultant

mail_icon linkedin_icon

Related Publications

Publication Preview Image

October 08 2024

Understanding and addressing healthcare inequity in the United States

Publication Preview Image

September 13 2024

Shifting the care paradigm for individuals with skin of color (SOC) in the United States

Publication Preview Image

August 14 2024

Building relationships: How Medical Affairs can advance healthcare improvement

Publication Preview Image

June 27 2024

Exploring the case for alternative access models

Publication Preview Image

April 18 2024

EU’s new Joint Clinical Assessment (JCA): will patients have a say?

Publication Preview Image

November 01 2023

Value-Based Healthcare (VBHC) in action: Key takeaways from ICHOM 2023

Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.